Normal adiponectin amounts significantly suppress the proliferation of MDA-MB-231 cancer cells [119], whereas decreased adiponectin is strongly correlated with TNBC development and progression, regardless of obesity and insulin resistance [120]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.